Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish
Source: SeekingAlpha
2026-02-24 13:30:20 ET
Investment Overview
Vir Biotechnology, Inc. ( VIR ) stock is soaring today , up nearly 30% in early trading, reaching >$9.5 per share, which reflects a market cap valuation of $1.33bn....
Read the full article on Seeking Alpha
For further details see:
Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish
Vir Biotechnology Inc.
NASDAQ: VIR
VIR Trading
-3.07% G/L:
$9.15 Last:
1,076,394 Volume:
$9.35 Open:
VIR Latest News
March 05, 2026 09:00:00 am
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
February 25, 2026 10:31:00 pm
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
VIR Stock Data
$1,054,567,743
108,239,275
0.82%
81
N/A
Biotechnology & Life Sciences
Healthcare
US
San Francisco
